Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| 1 |
Broadcom
AVGO
|
+$2.09B |
| 2 |
Mastercard
MA
|
+$2.06B |
| 3 |
UnitedHealth
UNH
|
+$1.3B |
| 4 |
Coca-Cola
KO
|
+$1.17B |
| 5 |
Marsh & McLennan
MMC
|
+$1.1B |
Top Sells
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$1.55B |
| 2 |
Apple
AAPL
|
+$1.51B |
| 3 |
JPMorgan Chase
JPM
|
+$1.34B |
| 4 |
General Dynamics
GD
|
+$1.25B |
| 5 |
Wells Fargo
WFC
|
+$1.17B |
Sector Composition
| 1 | Technology | 21.49% |
| 2 | Healthcare | 18.42% |
| 3 | Financials | 15.97% |
| 4 | Consumer Discretionary | 9.49% |
| 5 | Industrials | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BBOT
1476
BridgeBio Oncology Therapeutics, Inc. Common Stock
BBOT
$872M
| $2.09M | ﹤0.01% |
184,590
| – | – |
|
1477
BridgeBio Pharma
BBIO
$10.4B
| $2.07M | ﹤0.01% |
60,011
-4,796
| -7% | -$166K |
|
1478
Stellantis
STLA
$25.8B
| $2.06M | ﹤0.01% |
186,245
+5,163
| +3% | +$57.2K |
|
1479
General Mills
GIS
$26.9B
| $2.06M | ﹤0.01% |
34,390
+1,469
| +4% | +$87.8K |
|
1480
CNA Financial
CNA
$12.9B
| $2.05M | ﹤0.01% |
40,287
-1,383
| -3% | -$70.2K |
|
1481
Kiniksa Pharmaceuticals
KNSA
$2.71B
| $2.02M | ﹤0.01% |
91,032
+21,219
| +30% | +$471K |
|
1482
Aehr Test Systems
AEHR
$803M
| $2.02M | ﹤0.01% |
276,573
+75,500
| +38% | +$550K |
|
1483
Truist Financial
TFC
$58.4B
| $2.01M | ﹤0.01% |
48,955
-67,892
| -58% | -$2.79M |
|
1484
Schneider National
SNDR
$4.29B
| $2M | ﹤0.01% |
87,638
-1,802,375
| -95% | -$41.2M |
|
1485
VanEck Gold Miners ETF
GDX
$20.1B
| $2M | ﹤0.01% |
43,429
-59,358
| -58% | -$2.73M |
|
|
CNTA
1486
Centessa Pharmaceuticals
CNTA
$2.42B
| $2M | ﹤0.01% |
138,767
+23,660
| +21% | +$340K |
|
1487
Harrow
HROW
$1.45B
| $1.99M | ﹤0.01% |
74,739
-16,489
| -18% | -$439K |
|
1488
Strategy Inc Common Stock Class A
MSTR
$93.2B
| $1.96M | ﹤0.01% |
6,816
+3,251
| +91% | +$937K |
|
1489
Hershey
HSY
$38B
| $1.94M | ﹤0.01% |
11,371
+10,100
| +795% | +$1.73M |
|
1490
Campbell Soup
CPB
$10.1B
| $1.94M | ﹤0.01% |
48,600
+10,083
| +26% | +$403K |
|
1491
iShares MSCI Emerging Markets ETF
EEM
$19.5B
| $1.94M | ﹤0.01% |
44,373
-5,982
| -12% | -$261K |
|
1492
Brighthouse Financial
BHF
$2.48B
| $1.93M | ﹤0.01% |
33,334
-1,928
| -5% | -$112K |
|
1493
Mineralys Therapeutics
MLYS
$2.99B
| $1.93M | ﹤0.01% |
121,557
+30,028
| +33% | +$477K |
|
1494
Praxis Precision Medicines
PRAX
$858M
| $1.92M | ﹤0.01% |
50,776
-13,158
| -21% | -$498K |
|
1495
NetApp
NTAP
$24.2B
| $1.92M | ﹤0.01% |
21,884
+4,423
| +25% | +$389K |
|
1496
Financial Select Sector SPDR Fund
XLF
$54.1B
| $1.92M | ﹤0.01% |
38,567
-16,804
| -30% | -$837K |
|
1497
Constellation Energy
CEG
$94B
| $1.91M | ﹤0.01% |
9,479
+4,133
| +77% | +$833K |
|
1498
Krystal Biotech
KRYS
$4.2B
| $1.91M | ﹤0.01% |
10,599
-1,105
| -9% | -$199K |
|
1499
Eastman Chemical
EMN
$7.91B
| $1.9M | ﹤0.01% |
21,583
+4,683
| +28% | +$413K |
|
1500
Worthington Steel
WS
$1.63B
| $1.88M | ﹤0.01% |
74,339
+4,419
| +6% | +$112K |
|